MERCK & CO., INC. Chart calendar Merck & Co., Inc.
9fe902.Je81oo1OtHUVnIPPFIs5B1I0djDPSIX-3Eq8CwMm7dc.SthyyNgl0iR89uH3duZpb2UDHEm1fs-VhCvjUnMevINnpVbO4jviOXb2yg~aceb8d435421c53c27504cfbc1270e69
Upcoming events on Merck & Co., Inc.
Past events on Merck & Co., Inc.
| 2024-06-16 | Ex-dividend day |
| 2024-06-11 10:00 am | Goldman Sachs Global Healthcare Conference |
| 2024-06-03 07:00 pm | American Society of Clinical Oncology Meeting |
| 2024-05-30 | American Society of Clinical Oncology Meeting - Abstract No: 8012 |
| 2024-05-30 | American Society of Clinical Oncology Meeting - Abstract No: 9559 |
| 2024-05-30 | American Society of Clinical Oncology Meeting - Abstract No: 8502 |
| 2024-05-30 | American Society of Clinical Oncology Meeting - Abstract No: 4093 |
| 2024-05-30 | American Society of Clinical Oncology Meeting - Abstract No: 5502 |
| 2024-05-30 | American Society of Clinical Oncology Meeting - Abstract No: LBA4132 |
| 2024-05-30 | American Society of Clinical Oncology Meeting - Abstract No: 4100 |
| 2024-05-30 | American Society of Clinical Oncology Meeting - Abstract No: 4502 |
| 2024-05-30 | American Society of Clinical Oncology Meeting - Abstract No: 4045 |
| 2024-05-30 | American Society of Clinical Oncology Meeting - Abstract No: 9554 |
| 2024-05-30 | American Society of Clinical Oncology Meeting - Abstract No: LBA9512 |
| 2024-05-30 | American Society of Clinical Oncology Meeting - Abstract No: 104 |
| 2024-05-28 09:00 am | Annual General Meeting |
| 2024-05-15 04:40 pm | BofA Securities Health Care Conference |
| 2024-04-25 09:00 am | Q1 2024 Earnings Call |
| 2024-04-25 06:30 am | Q1 2024 Earnings Release |
| 2024-03-13 | Ex-dividend day |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 46 840 46 818 0.05% | 47 994 48 177 -0.38% | 48 704 48 367 0.7% | 59 283 59 144 0.24% | 60 115 59 938 0.3% | 64 175 |
|
EBITDA Million USD | Released Forecast Spread | 19 572 18 761 4.32% | 20 570 19 815 3.81% | 20 910 19 760 5.82% | 26 431 24 588 7.5% | 10 083 9 362 7.71% | 29 271 |
|
EBIT Million USD | Released Forecast Spread | 15 920 16 276 -2.19% | 16 945 17 366 -2.43% | 17 696 17 554 0.81% | 22 522 22 363 0.71% | 6 211 6 066 2.4% | 26 246 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 11 464 12 277 -6.62% | 8 791 14 906 -41.02% | 13 879 12 048 15.2% | 16 444 17 389 -5.44% | 1 889 2 857 -33.89% | 23 998 |
|
Net income Million USD | Released Forecast Spread | 9 843 9 957 -1.15% | 7 067 12 094 -41.57% | 13 049 11 797 10.61% | 14 519 14 827 -2.07% | 365 1 682 -78.3% | 19 507 |
|
EPS USD | Released Forecast Spread | 3,81 3,83 -0.52% | 2,78 4,71 -41% | 5,14 4,70 9.39% | 5,71 5,87 -2.73% | 0,14 0,56 -75.16% | 7,75 |
| Announcement Date | 05/02/20 | 04/02/21 | 03/02/22 | 02/02/23 | 01/02/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 15 901 14 648 8.55% | 14 593 13 861 5.28% | 14 959 14 043 6.52% | 13 830 13 676 1.12% | 14 487 13 799 4.98% | 15 035 14 450 4.05% | 15 962 15 273 4.51% | 14 630 14 480 1.03% | 15 775 15 204 3.75% | 15 820 | 16 667 | 15 956 | 16 565 | 17 490 |
|
EBITDA Million USD | Released Forecast Spread | 7 568 5 918 27.88% | 6 649 6 064 9.65% | 6 516 6 275 3.85% | 5 698 5 183 9.94% | 5 402 5 058 6.8% | -3 485 -3 901 10.67% | 7 538 6 724 12.1% | 665 1 985 -66.49% | 7 367 6 562 12.27% | 7 364 | 8 236 | 7 613 | ||
|
EBIT Million USD | Released Forecast Spread | 6 448 5 393 19.56% | 5 711 5 157 10.75% | 5 557 5 268 5.49% | 4 806 4 592 4.66% | 4 411 4 088 7.89% | -4 388 -4 683 6.29% | 6 524 5 967 9.33% | -299 -476 37.23% | 6 383 5 808 9.91% | 6 504 | 7 018 | 6 279 | ||
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 3 583 3 956 -9.43% | 3 513 3 391 3.6% | 3 650 4 190 -12.89% | -5 335 -4 682 -13.95% | 5 620 5 023 11.89% | -2 046 -1 249 -63.78% | 5 670 5 267 7.66% | 6 044 | 6 461 | 5 750 | ||||
|
Net income Million USD | Released Forecast Spread | 4 310 3 768 14.4% | 3 944 3 859 2.19% | 3 248 3 477 -6.6% | 3 017 3 016 0.02% | 2 821 3 133 -9.97% | -5 975 -6 154 2.9% | 4 745 4 224 12.34% | -1 226 -919 -33.43% | 4 762 4 414 7.88% | 4 955 | 5 443 | 4 814 | ||
|
EPS USD | Released Forecast Spread | 1,70 1,48 14.96% | 1,55 1,48 4.46% | 1,28 1,42 -10.11% | 1,18 1,20 -1.99% | 1,11 1,21 -8.14% | -2,35 -2,44 3.61% | 1,86 1,65 12.59% | -0,48 -0,35 -37.91% | 1,87 1,79 4.45% | 1,94 | 2,12 | 1,94 | ||
| Announcement Date | 28/04/22 | 28/07/22 | 27/10/22 | 02/02/23 | 27/04/23 | 01/08/23 | 26/10/23 | 01/02/24 | 25/04/24 | - | - | - | - | - |
More events
Past sector events for Merck & Co., Inc.
| 2024-06-13 05:21 pm | EIS ECZACIBASI ILAÇ, SINAI VE FINANSAL YATIRIMLAR SANAYI VE TICARET: Q1 2024 Earnings Release |
| 2024-06-11 01:30 am | BORA PHARMACEUTICALS CO., LTD.: June 2024 Sales and Revenue Release |
| 2024-06-07 06:33 am | SCINOPHARM TAIWAN, LTD.: May 2024 Sales and Revenue Release |
| 2024-06-07 05:17 am | LOTUS PHARMACEUTICAL CO., LTD.: May 2024 Sales and Revenue Release |
| 2024-05-30 08:08 am | SUVEN PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release |
| 2024-05-30 07:00 am | ROIVANT SCIENCES LTD.: Q4 2023 Earnings Release |
| 2024-05-30 02:24 am | MARKSANS PHARMA LIMITED: Q4 2024 Earnings Release |
| 2024-05-29 08:00 am | FDC LIMITED: Q4 2024 Earnings Release |
| 2024-05-29 05:26 am | JUBILANT PHARMOVA LIMITED: Q4 2024 Earnings Release |
| 2024-05-29 04:44 am | ALKEM LABORATORIES LIMITED: Q4 2024 Earnings Release |
